| Secondary |
| Myocardial Infarction |
20.5% |
| Deep Vein Thrombosis |
13.6% |
| Extradural Abscess |
13.6% |
| Anticoagulant Therapy |
9.1% |
| Pemphigus |
9.1% |
| Arteriogram Coronary |
6.8% |
| Dyspnoea |
6.8% |
| Renal Cell Carcinoma |
6.8% |
| Peripheral Ischaemia |
4.5% |
| Depression |
2.3% |
| Essential Hypertension |
2.3% |
| Hyperlipidaemia |
2.3% |
| Psoriasis |
2.3% |
|
| Thrombocytopenia |
20.0% |
| Urosepsis |
20.0% |
| Haematuria |
13.3% |
| Visual Impairment |
13.3% |
| Abdominal Pain |
6.7% |
| Hypersensitivity |
6.7% |
| Pulmonary Embolism |
6.7% |
| Tachycardia |
6.7% |
| Urticaria |
6.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
17.5% |
| Prophylaxis |
14.5% |
| Hypertension |
11.8% |
| Product Used For Unknown Indication |
10.2% |
| Thrombosis Prophylaxis |
6.1% |
| Prophylaxis Of Nausea And Vomiting |
4.7% |
| Abdominal Pain |
3.5% |
| Colorectal Cancer |
3.1% |
| Breast Cancer |
2.9% |
| Non-small Cell Lung Cancer |
2.9% |
| Acute Myeloid Leukaemia |
2.7% |
| Plasma Cell Myeloma |
2.5% |
| Small Cell Lung Cancer Stage Unspecified |
2.5% |
| Pyrexia |
2.4% |
| Bronchitis |
2.2% |
| Chest Pain |
2.2% |
| Colorectal Cancer Metastatic |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Multiple Myeloma |
2.0% |
| Non-small Cell Lung Cancer Stage Iv |
2.0% |
|
| Renal Failure Acute |
13.4% |
| Pneumonitis |
9.0% |
| Sepsis |
9.0% |
| Pneumonia |
6.0% |
| Fungal Infection |
4.5% |
| Haematuria |
4.5% |
| Muscular Weakness |
4.5% |
| Pyrexia |
4.5% |
| Rash |
4.5% |
| Retinal Vein Thrombosis |
4.5% |
| Rhabdomyolysis |
4.5% |
| Tumour Necrosis |
4.5% |
| Weight Decreased |
4.5% |
| Wound Infection |
4.5% |
| Alanine Aminotransferase Increased |
3.0% |
| Bacteria Urine |
3.0% |
| Brain Oedema |
3.0% |
| Deafness Bilateral |
3.0% |
| Diabetes Mellitus |
3.0% |
| Diverticulitis |
3.0% |
|
| Interacting |
| Hypertension |
26.7% |
| Type 2 Diabetes Mellitus |
20.0% |
| Pain |
15.6% |
| Bacterial Infection |
13.3% |
| Acute Myocardial Infarction |
4.4% |
| Antiplatelet Therapy |
4.4% |
| Ischaemic Stroke |
4.4% |
| Product Used For Unknown Indication |
4.4% |
| Deep Vein Thrombosis |
2.2% |
| Infection |
2.2% |
| Prophylaxis |
2.2% |
|
| Drug Interaction |
44.4% |
| Condition Aggravated |
11.1% |
| Haematoma |
11.1% |
| Hypoglycaemic Coma |
11.1% |
| Intra-abdominal Haematoma |
11.1% |
| Peripheral Artery Thrombosis |
11.1% |
|
